Blockade of mIL‐6R alleviated lipopolysaccharide‐induced systemic inflammatory response syndrome by suppressing NF‐κB‐mediated Ccl2 expression and inflammasome activation
Abstract Systemic inflammatory response syndrome (SIRS) is characterized by dysregulated cytokine release, immune responses and is associated with organ dysfunction. IL‐6R blockade indicates promising therapeutic effects in cytokine release storm but still remains unknown in SIRS. To address the iss...
Main Authors: | Ji‐Min Dai, Xue‐Qin Zhang, Jia‐Jia Zhang, Wei‐Jie Yang, Xiang‐Min Yang, Huijie Bian, Zhi‐Nan Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | MedComm |
Subjects: | |
Online Access: | https://doi.org/10.1002/mco2.132 |
Similar Items
-
Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway
by: Han X, et al.
Published: (2022-12-01) -
CHEMOKINES CCL17 AND CCL22 IN SARCOIDOSIS
by: N. M. Lazareva, et al.
Published: (2021-10-01) -
CCL13 and human diseases
by: Laifu Li, et al.
Published: (2023-04-01) -
Advances in Metal-Organic Frameworks MIL-101(Cr)
by: Minmin Zou, et al.
Published: (2022-08-01) -
Liquiritin Protects Against Cardiac Fibrosis After Myocardial Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway [Letter]
by: Idrus HH, et al.
Published: (2023-02-01)